Literature DB >> 31937979

Development of a catalytic enantioselective synthesis of the guanacastepene and heptemerone tricyclic core.

Andrew M Harned1,2, Brian M Stoltz1.   

Abstract

For nearly two decades, synthetic chemists have been fascinated by the structural complexity and synthetic challenges afforded by the guanacastepene and heptemerone diterpenoids.Numerous synthetic approaches to these compounds have been reported, but to date the application of enantioselective catalysis to this problem has not been realized. Herein we report an enantioselective synthesis of an advanced intermediate corresponding to the tricyclic core common to the guanacastepenes and heptemerones. Highlights of this work include sequential Pd-catalyzed decarboxylative allylic alkylation reactions to generate the two all carbon quaternary stereocenters, the use of ring-closing metathesis to close the A ring in the presence of a distal allyl sidechain, and a region and diastereoselective oxidation of an trienol ether to introduce oxygenation on the A ring.

Entities:  

Keywords:  Pd catalysis; allylic alkylation; natural products; olefin metathesis; stereoselectivity

Year:  2019        PMID: 31937979      PMCID: PMC6959853          DOI: 10.1016/j.tet.2019.02.053

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  38 in total

1.  The guanacastepenes: a highly diverse family of secondary metabolites produced by an endophytic fungus.

Authors:  S F Brady; S M Bondi; J Clardy
Journal:  J Am Chem Soc       Date:  2001-10-10       Impact factor: 15.419

2.  Heptemerones A-G, seven novel diterpenoids from Coprinus heptemerus: producing organism, fermentation, isolation and biological activities.

Authors:  Melanie Kettering; Carola Valdivia; Olov Sterner; Heidrun Anke; Eckhard Thines
Journal:  J Antibiot (Tokyo)       Date:  2005-06       Impact factor: 2.649

3.  Total synthesis of sordaricin.

Authors:  Lewis N Mander; Regan J Thomson
Journal:  J Org Chem       Date:  2005-03-04       Impact factor: 4.354

4.  Deracemization of quaternary stereocenters by Pd-catalyzed enantioconvergent decarboxylative allylation of racemic beta-ketoesters.

Authors:  Justin T Mohr; Douglas C Behenna; Andrew M Harned; Brian M Stoltz
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-28       Impact factor: 15.336

5.  The catalytic asymmetric total synthesis of elatol.

Authors:  David E White; Ian C Stewart; Robert H Grubbs; Brian M Stoltz
Journal:  J Am Chem Soc       Date:  2007-12-29       Impact factor: 15.419

6.  Total syntheses of guanacastepenes N and O.

Authors:  Christian M Gampe; Erick M Carreira
Journal:  Angew Chem Int Ed Engl       Date:  2011-03-02       Impact factor: 15.336

7.  Synthetic study of 1,3-butadiene-based IMDA approach to construct a [5-7-6] tricyclic core and its application to the total synthesis of C8-epi-guanacastepene O.

Authors:  Chuang-Chuang Li; Cui-Hua Wang; Bo Liang; Xin-Hao Zhang; Lu-Jiang Deng; Shuang Liang; Jia-Hua Chen; Yun-Dong Wu; Zhen Yang
Journal:  J Org Chem       Date:  2006-09-01       Impact factor: 4.354

8.  Enantioselective decarboxylative alkylation reactions: catalyst development, substrate scope, and mechanistic studies.

Authors:  Douglas C Behenna; Justin T Mohr; Nathaniel H Sherden; Smaranda C Marinescu; Andrew M Harned; Kousuke Tani; Masaki Seto; Sandy Ma; Zoltán Novák; Michael R Krout; Ryan M McFadden; Jennifer L Roizen; John A Enquist; David E White; Samantha R Levine; Krastina V Petrova; Akihiko Iwashita; Scott C Virgil; Brian M Stoltz
Journal:  Chemistry       Date:  2011-11-14       Impact factor: 5.236

9.  Access to a Guanacastepene and Cortistatin-Related Skeleton via Ethynyl Lactone Ireland-Claisen Rearrangement and Transannular (4 + 3)-Cycloaddition of an Azatrimethylenemethane Diyl.

Authors:  Oleksandr Zhurakovskyi; Sam R Ellis; Amber L Thompson; Jeremy Robertson
Journal:  Org Lett       Date:  2017-04-11       Impact factor: 6.005

10.  A facile and modular synthesis of phosphinooxazoline ligands.

Authors:  Kousuke Tani; Douglas C Behenna; Ryan M McFadden; Brian M Stoltz
Journal:  Org Lett       Date:  2007-05-31       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.